Introduction
Newcastle Disease Virus (NDV) remains a significant threat to the global poultry industry due to its high contagiousness and devastating impact. Developing robust diagnostic and therapeutic tools is critical for managing outbreaks. Camelid-derived single-domain antibodies, known as VHHs or nanobodies, offer a promising solution. Their small size and high stability make them superior to conventional antibodies in various biotechnological applications. This paper presents a formal correction to a 2016 study that utilized a Yeast Two-Hybrid (Y2H) system to identify VHHs targeting the haemagglutinin-neuraminidase (HN) protein of NDV.
Methodology
The original study employed a Y2H screening process to identify high-affinity binders from a camelid VHH library. The HN protein of NDV served as the "bait," fused to a DNA-binding domain (pBD-HN). The "prey" consisted of a library of camelid VHH sequences fused to an activation domain (pAD-VHH).
A successful interaction between a VHH (prey) and the HN protein (bait) reconstitutes the transcription factor, triggering the expression of reporter genes. This allows the yeast to grow on highly selective media, such as Quadruple Dropout (QDO/X/A) plates, and typically results in blue coloration due to X-α-Gal activity.
The Correction: Ensuring Data Integrity
This correction notice addresses visual inaccuracies in the original Figure 1. The authors identified that several panels in the 2016 publication did not accurately represent the experimental yeast colony morphologies. Specifically, the shapes and growth patterns of colonies in key experimental and control panels were corrected to align with the actual laboratory results.
Results and Discussion
The corrected Figure 1 provides the definitive visual evidence for the selection of VHH binders.
Validation of Binders
The screening results on highly selective QDO/X/A plates (Bait 4) confirm that clones VHH1 through VHH7 are successful binders to the HN protein. These clones exhibit robust growth and characteristic blue coloration, distinguishing them from the negative control (Bait 4, Prey A), which shows growth but lacks the specific interaction-driven reporter expression seen in the experimental groups.
Control Consistency
The correction ensures that both positive and negative controls are accurately depicted, providing a reliable baseline for interpreting the VHH interactions. For instance, the interaction between pGBKT7-p53 and pGADT7-T (positive control) shows expected growth and blue color on QDO/X/A plates, while the pGBKT7-Lam and pGADT7-T (negative control) shows no growth on the same medium.
Significance of the Update
In molecular biology, the morphology of a yeast colony—its shape, density, and color—is a direct qualitative indicator of the strength of a protein-protein interaction. By rectifying these visual errors, the authors maintain the integrity of the scientific record and ensure that the published evidence accurately supports the study's conclusions regarding the efficacy of the selected nanobodies.
Conclusion
This correction reinforces the importance of precision in scientific reporting. The updated Figure 1 confirms the successful construction of a camelid VHH library and the identification of specific nanobodies against the NDV HN protein, providing a solid foundation for future diagnostic and therapeutic development against Newcastle Disease.
Summary updated